Dexmedetomidine vs Remifentanil infusion for conscious sedation for awake intubation with the Modified Flexible Fiberoptic

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13003151

Enrollment

Unknown

Registered

2013-04-13

Start date

2013-03-20

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

difficult airway

Interventions

Re:remifentanil

control:dexmedetomidine

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with difficult airway for selective operation or volunteers under selective surgery need trecheal intubation over month, ASA I-III.

Exclusion criteria

Exclusion criteria: 1) ASA IV or V aged more than 60y or age less than 18y; 2) Month opengning less then 15mm; 3) Poor dental conditions; 4) Surgery requires nasal intubation or taboo intratracheal injection; 5) Patients can not match; 6) Oral hemorrhage or tumor.

Design outcomes

Primary

Measure	Time frame
To achieve the required depth of sedation time;Intubation time;The number of endotracheal intubation;the frequency of SpO2<90%;Intubating condition;	—

Countries

China

Contacts

Public ContactHuihui Liu?Jianqi Wei

gzylhh@163.com+86 13926007569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026